Inventor · disambiguated record
Pulla Reddy Muddasani
Also filed as: MUDDASANI PULLA REDDY
9 granted patents·9 pending applications·2 citations·filing 2009–2022
74Inventor score
Top patents by PatentIndex Score
18 records- 0165US8759582B2Process for the preparation of lacosamideMUDDASANI PULLA REDDY·Filed 2011·Granted Jun 24, 2014·2 cites·11 claims
- 0258US2024199637A1Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivativesNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 0354US2024352039A1Novel crystalline polymorph of lurbinectedin and improved process for the preparation of lurbinectedinNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 0453US2024376102A1An improved process for the preparation of ruxolitinib phosphateNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 0553US2025026732A1An improved process for the preparation of crystalline form-a of cyantraniliproleNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 0648US11465988B2Process for the preparation of Tipiracil hydrochloride and intermediates thereofNATCO PHARMA LTD·Filed 2019·Granted Oct 11, 2022·0 cites·8 claims
- 0748US2024294549A1An improved process for the preparation of trabectedinNATCO PHARMA LTD·Filed 2022·Application pending·0 cites
- 0846US11008296B2Intermediates for the preparation of eribulin thereofNATCO PHARMA LTD·Filed 2018·Granted May 18, 2021·0 cites·10 claims
- 0946US2022259204A1A process for the preparation of venetoclax and its polymorphs thereofNATCO PHARMA LTD·Filed 2020·Application pending·0 cites
- 1045US10870650B2Process for the preparation of amorphous idelalisibNATCO PHARMA LTD·Filed 2018·Granted Dec 22, 2020·0 cites·17 claims
- 1142US2012058200A1Process for the preparation of lanthanum carbonate dihydrateMUDDASANI PULLA REDDY·Filed 2009·Application pending·0 cites
- 1237US10626117B2Process for the preparation of IbrutinibNATCO PHARMA LTD·Filed 2017·Granted Apr 21, 2020·0 cites·13 claims
- 1337US10604505B2Modified process for the preparation of Ceritinib and amorphous form of CeritinibNATCO PHARMA LTD·Filed 2017·Granted Mar 31, 2020·0 cites·7 claims
- 1436US10106554B27-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugsNATCO PHARMA LTD·Filed 2014·Granted Oct 23, 2018·0 cites·7 claims
- 1535US9227948B2Process for the preparation of 2-substituted-2-(6-(substituted)-7-methylbenzo[D][1,3]dioxol-4-yl)acetic acid derivativesNATCO PHARMA LTD·Filed 2013·Granted Jan 5, 2016·0 cites·27 claims
- 1634US11091470B2Process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochlorideNATCO PHARMA LTD·Filed 2017·Granted Aug 17, 2021·0 cites·9 claims
- 1731US2012172380A1Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agentKONAKANCHI DURGA PRASAD·Filed 2011·Application pending·0 cites
- 1828US2019300484A1An improved process for the preparation of regorafenibNATCO PHARMA LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pulla Reddy Muddasani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →